---
title: "VIVA BIOTECH repurchased VIVA Shanghai's obligations, temporarily suspended by investors"
description: "VIVA BIOTECH announced that investors in VIVA Shanghai agreed to temporarily suspend their rights to repurchase equity between December 31, 2026, and December 31, 2028. These investors include HLC SPV"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/271517952.md"
published_at: "2026-01-05T13:07:51.000Z"
---

# VIVA BIOTECH repurchased VIVA Shanghai's obligations, temporarily suspended by investors

> VIVA BIOTECH announced that investors in VIVA Shanghai agreed to temporarily suspend their rights to repurchase equity between December 31, 2026, and December 31, 2028. These investors include HLC SPV, Qingdao Hongyi, Daxue Investments, True Light P, and Raed Capital Holdings 2. According to the shareholder agreement, investors have the right to repurchase their held equity if VIVA Shanghai fails to complete a qualified initial public offering or achieve a qualified merger and acquisition transaction by December 31, 2026

VIVA BIOTECH (01873.HK) announced that the company received a letter from VIVA Shanghai investors (including HLC SPV, Qingdao Hongyi, Daxue Investments, True Light P, and Raed Capital Holdings 2), irrevocably agreeing to temporarily suspend their right to require the company to repurchase their equity in VIVA Shanghai under the repurchase obligation at any time from December 31, 2026, to December 31, 2028.

According to the shareholder agreement, VIVA Shanghai investors have the right to repurchase their equity if VIVA Shanghai fails to complete a qualified initial public offering or achieve a qualified merger and acquisition transaction by December 31, 2026

### Related Stocks

- [01873.HK - VIVA BIOTECH](https://longbridge.com/en/quote/01873.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| VIVA Biotech Investors Suspend Repurchase Rights for Shanghai VIVA Equity | VIVA Biotech Holdings announced that investors, including HLC SPV and others, have temporarily suspended their right to  | [Link](https://longbridge.com/en/news/271493678.md) |
| Viva Biotech Expands Pharmacology Platform to Support Diverse Drug Modalities | Viva Biotech Holdings has expanded its pharmacology platform, enhancing DMPK, pharmacology, and efficacy services. The c | [Link](https://longbridge.com/en/news/270955785.md) |
| Truespeed and Freedom Fibre Merge to Form Scaled UK Fibre Platform | Truespeed Communications and Freedom Fibre have merged to create a larger full fibre platform serving 412,000 premises a | [Link](https://longbridge.com/en/news/275637942.md) |
| HSBC Bank Makes Early Repurchase of $14 Million USD Notes | HSBC Bank Makes Early Repurchase of $14 Million USD Notes | [Link](https://longbridge.com/en/news/275792057.md) |
| Kangqiao Service Says On Feb 12 Unit Received Civil Judgment | Kangqiao Service Group Ltd :ON FEB 12 UNIT RECEIVED CIVIL JUDGMENT FROM COURT IN RELATION TO APPEALCONSIDERS SECOND CIVI | [Link](https://longbridge.com/en/news/275924000.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.